Evidence map›Paper›PMID 33312215›Full record

ArticleResearch in pharmaceutical sciences2020

Anti-

Mohammadsaeid Zahedi, Qasem Asgari, Fatemeh Badakhshan, Amirhossein Sakhteman, Sara Ranjbar, Mehdi Khoshneviszadeh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research in pharmaceutical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mohammadsaeid ZahediDepartment of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Qasem AsgariDepartment of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Fatemeh BadakhshanDepartment of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Amirhossein SakhtemanDepartment of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Sara RanjbarPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Mehdi KhoshneviszadehDepartment of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe aim of this study was to evaluate the EXPERIMENTAL APPROACH: A number of 5-oxo-hexahydoquinoline derivatives (Z1-Z4) were synthesized. The FINDINGS /

resultsFlow cytometry assay results indicated compounds Z3 and Z4 had relevant mortality effect on parasite tachyzoites. Besides, CONCLUSION AND IMPLICATIONS: Compounds Z3 and Z4 are good leads in order to develop better anti-

Indexed as

5-Oxo-hexahydroquinolineFlow cytometryMolecular dockingPropidium iodideToxoplasma

Identifiers

PMID33312215
PMCPMC7714012
OpenAlexW3082698145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.